Publications by authors named "B Kang"

Claim this Profile
O
Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study.
Jung Sun Kim, Jeffrey Wong, San-Chi Chen, David Tai, Hannah Yang, Beodeul Kang

Liver Int· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Parenteral Amino Acid Composition on Hyperammonemia in a Cat with Hepatic Lipidosis.
Jinyeong Park, Byeong-Teck Kang, Yerim Lee, Taesik Yun, Hakhyun Kim

J Am Anim Hosp Assoc· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression.
Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung Mo Kang, Michael Bouvet

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging Acidic and Alkaline Hydrogen Electrocatalysis via Ru-Modified PtCo for Waste-to-Energy Electrochemical Neutralization Fuel Cells.
Yiran Lin, Songheng Xie, Kai Chen, Junxiang Chen, Biyu Kang

Adv Mater· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.
Daeseong Kim, Nam Suk Sim, Seonjeong Woo, Min Hwan Kim, Choong-Kun Lee, Chang Moo Kang, Beodeul Kang

Clin Mol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis